We have located links that may give you full text access.
Depressed female smokers have higher levels of soluble tumor necrosis factor receptor 1.
Addictive Behaviors Reports 2018 June
Aim: To examine clinical and biomarkers in depressed female smokers, in order to better clarify the process that link mood disorders, childhood trauma and smoking in women.
Methods: The clinical sample comprised women with unipolar or bipolar depression, divided into subgroups of smokers and never-smoker. The control groups comprised two subgroups non-depressed women, separated into smokers and never-smokers. A structured questionnaire was used to assess socio-demographic and clinical data. The following scales were used: 17-item version Hamilton Depression Rating Scale, Hamilton Anxiety Rating scale (HAM-A), Sheehan disability scale, the Child Trauma Questionnaire. The following biomarkers were investigated: lipid profile, including total cholesterol, high-density lipoprotein cholesterol (HDLc), low-density lipoprotein cholesterol, triglycerides the Castelli's Risk indexes I and II; and cytokines, including interleukins (IL)-1β, IL-6, IL-10, IL-12, soluble tumor necrosis factor receptor 1 (sTNF-R1).
Results: Depressed female smokers showed a number of significant positive correlations: emotional neglect and sTNF-R1 ( p = 0.02); waist circumference and sTNF-R1 ( p = 0.001); body mass index and sTNF-R1 ( p < 0.01); HAM-A and sTNF-R1 ( p = 0.03); IL-1β and sTNF-R1 ( p < 0.01); IL-10 and sTNF-R1 ( p = 0.001); IL-12 and sTNF-R1 ( p < 0.01);Castelli index I and sTNF-R1 ( p < 0.01); Castelli index II and sTNF-R1 ( p < 0.01); and a significantly negative correlation between HDLc and sTNF-R1( p = 0.014).
Conclusion: This study suggests that depressed female smokers who experienced more childhood trauma and had more anxiety symptoms are associated with the activation of inflammatory processes and alterations in components of lipid profile.
Methods: The clinical sample comprised women with unipolar or bipolar depression, divided into subgroups of smokers and never-smoker. The control groups comprised two subgroups non-depressed women, separated into smokers and never-smokers. A structured questionnaire was used to assess socio-demographic and clinical data. The following scales were used: 17-item version Hamilton Depression Rating Scale, Hamilton Anxiety Rating scale (HAM-A), Sheehan disability scale, the Child Trauma Questionnaire. The following biomarkers were investigated: lipid profile, including total cholesterol, high-density lipoprotein cholesterol (HDLc), low-density lipoprotein cholesterol, triglycerides the Castelli's Risk indexes I and II; and cytokines, including interleukins (IL)-1β, IL-6, IL-10, IL-12, soluble tumor necrosis factor receptor 1 (sTNF-R1).
Results: Depressed female smokers showed a number of significant positive correlations: emotional neglect and sTNF-R1 ( p = 0.02); waist circumference and sTNF-R1 ( p = 0.001); body mass index and sTNF-R1 ( p < 0.01); HAM-A and sTNF-R1 ( p = 0.03); IL-1β and sTNF-R1 ( p < 0.01); IL-10 and sTNF-R1 ( p = 0.001); IL-12 and sTNF-R1 ( p < 0.01);Castelli index I and sTNF-R1 ( p < 0.01); Castelli index II and sTNF-R1 ( p < 0.01); and a significantly negative correlation between HDLc and sTNF-R1( p = 0.014).
Conclusion: This study suggests that depressed female smokers who experienced more childhood trauma and had more anxiety symptoms are associated with the activation of inflammatory processes and alterations in components of lipid profile.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app